Recurrence-free survival as a surrogate endpoint for overall survival after neoadjuvant chemotherapy and surgery for oesophageal squamous cell carcinoma.
Okui J, Nagashima K, Matsuda S, Sato Y, Okamura A, Kawakubo H, Muto M, Kakeji Y, Kono K, Takeuchi H, Watanabe M, Doki Y, Bamba T, Fukuda T, Fujiwara H, Sato S, Noma K, Miyata H, Fujita T, Kitagawa Y.
Okui J, et al. Among authors: okamura a.
Br J Surg. 2024 Jan 31;111(2):znae038. doi: 10.1093/bjs/znae038.
Br J Surg. 2024.
PMID: 38377361
Free PMC article.